David Tyronne Howton, Jr
2013
In 2013, David Tyronne Howton, Jr earned a total compensation of $2.6M as Senior Vice President, General Counsel and Corporate Secretary at Sarepta Therapeutics, a 7% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $165,178 |
|---|---|
| Option Awards | $2,086,290 |
| Salary | $376,913 |
| Other | $12,518 |
| Total | $2,640,899 |
Howton received $2.1M in option awards, accounting for 79% of the total pay in 2013.
Howton also received $165.2K in non-equity incentive plan, $376.9K in salary and $12.5K in other compensation.
Rankings
In 2013, David Tyronne Howton, Jr's compensation ranked 2,939th out of 12,286 executives tracked by ExecPay. In other words, Howton earned more than 76.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,939 out of 12,286 | 76th |
Division Manufacturing | 976 out of 4,614 | 79th |
Major group Chemicals And Allied Products | 257 out of 1,466 | 83rd |
Industry group Drugs | 175 out of 1,160 | 85th |
Industry Pharmaceutical Preparations | 145 out of 890 | 84th |
Source: SEC filing on May 31, 2016.
Howton's colleagues
We found four more compensation records of executives who worked with David Tyronne Howton, Jr at Sarepta Therapeutics in 2013.